[Long-term efficacy and tolerability of omeprazole in 20 patients with severe Zollinger-Ellison syndrome].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 2806801)

Published in Gastroenterol Clin Biol on December 15, 1989

Authors

J F Cadranel1, P Ruszniewski, L Elouaer-Blanc, T Lehy, J C Delchier, G Cadiot, C Florent, J Vatier, M Mignon

Author Affiliations

1: Service d'Hépato-Gastroentérologie, Hôpital Bichat, Paris.

Articles citing this

Zollinger-Ellison syndrome: past, present and future controversies. Yale J Biol Med (1996) 0.75

Articles by these authors

The stomach is a source of leptin. Nature (1998) 3.33

Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria. J Hepatol (1993) 3.24

Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med (2001) 2.95

Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol (2000) 2.58

Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol (2004) 2.54

Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology (2005) 2.49

Leptin secretion and leptin receptor in the human stomach. Gut (2000) 2.46

Olmesartan-associated enteropathy: results of a national survey. Aliment Pharmacol Ther (2014) 2.42

The natural history of hereditary pancreatitis: a national series. Gut (2008) 2.33

Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut (2002) 2.21

Diagnostic value of endoscopic capsule in patients with obscure digestive bleeding: blinded comparison with video push-enteroscopy. Endoscopy (2003) 2.20

Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma? Ann Oncol (2005) 2.20

Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau. Gastroenterology (2000) 2.16

Treatment of Crohn's disease by lymphocyte apheresis: a randomized controlled trial. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gastroenterology (1994) 2.07

Sialic acid content and proteolytic activity in gastric juice in humans. An approach for appreciating mucus glycoprotein erosion. Dig Dis Sci (1988) 2.06

Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gut (1994) 2.03

Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study). J Clin Invest (1985) 2.00

Assessment of complications of EUS-guided fine-needle aspiration. Gastrointest Endosc (2001) 1.94

Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut (2002) 1.85

Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals. Vaccine (1993) 1.75

Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID) Gastroenterology (1993) 1.71

Utilization of paraffin-embedded material for electron microscopy. Study of an A2-cell type microadenoma of the endocrine pancreas. Lab Invest (1970) 1.70

False-positive somatostatin receptor scintigraphy due to an accessory spleen. J Nucl Med (1997) 1.67

TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst (2012) 1.65

Detection and monitoring of serum p53 antibodies in patients with colorectal cancer. Gut (1997) 1.64

Control of acute Zollinger-Ellison syndrome with intravenous omeprazole. Lancet (1982) 1.63

Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses. Gut (2000) 1.63

Expression of vascular endothelial growth factor in digestive neuroendocrine tumours. Histopathology (1998) 1.61

Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems? Endoscopy (2010) 1.60

Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines. Infect Immun (1995) 1.60

Multicentre prospective controlled study of Barrett's oesophagus and colorectal adenomas. Groupe d'Etude de l'Oesophage de Barrett. Lancet (1995) 1.59

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial. Gut (2005) 1.58

Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumours. Eur J Gastroenterol Hepatol (2000) 1.57

[How to express results of 24-hour gastric pH measurement? Choice of a mode of expression in 27 healthy subjects]. Gastroenterol Clin Biol (1989) 1.51

Preoperative cyst fluid analysis is useful for the differential diagnosis of cystic lesions of the pancreas. Gastroenterology (1995) 1.51

Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA. Br J Cancer (2002) 1.47

[Comparison of quantifying Helicobacter pylori gastric infection by culture, histology and C13 urea breath test]. Gastroenterol Clin Biol (1998) 1.46

Ischaemic colitis in a patient taking meloxicam. Lancet (2001) 1.45

Duodenogastric reflux in children: measurement of phospholipids and trypsin in gastric content. J Pediatr Gastroenterol Nutr (1990) 1.44

Use of scanning electron microscopy to investigate dental calculus in dogs. Vet Rec (1990) 1.43

Diagnosis of protein-losing enteropathy by gastrointestinal clearance of alpha1-antitrypsin. Lancet (1978) 1.41

Normal serum gastrin concentration in gastrinoma. Lancet (1995) 1.39

Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gastroenterology (1992) 1.39

Intestinal clearance of alpha 1-antitrypsin. A sensitive method for the detection of protein-losing enteropathy. Gastroenterology (1981) 1.39

Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. Am J Transplant (2008) 1.38

[Dysphagia revealing Crohn's disease]. Gastroenterol Clin Biol (1998) 1.38

Functional and morphological changes in the pancreatic remnant following pancreaticoduodenectomy with pancreaticogastric anastomosis. Br J Surg (2000) 1.37

Prognostic factors in patients with endocrine tumours of the duodenopancreatic area. Gut (1998) 1.37

[Cerebrovascular accidents after endoscopic obturation of esophageal varices with isobutyl-2-cyanoacrylate in 2 patients]. Gastroenterol Clin Biol (1987) 1.33

M or M-like protein gene polymorphisms in human group G streptococci. J Clin Microbiol (1995) 1.31

Frequent association between alteration of the rdxA gene and metronidazole resistance in French and North African isolates of Helicobacter pylori. Antimicrob Agents Chemother (2000) 1.31

Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology (2000) 1.28

Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet. Gut (1991) 1.28

Results of surgical management in 92 consecutive patients with Zollinger-Ellison syndrome. Ann Surg (1981) 1.27

Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance. Cancer (2000) 1.26

Evaluation of recombinant transferrin-binding protein B variants from Neisseria meningitidis for their ability to induce cross-reactive and bactericidal antibodies against a genetically diverse collection of serogroup B strains. Infect Immun (1997) 1.25

Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. Br J Cancer (2005) 1.24

Splenic complications in chronic pancreatitis: prevalence and risk factors in a medical-surgical series of 500 patients. Br J Surg (1998) 1.24

Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer (1993) 1.23

Prevalence of high-grade dysplasia and cancer in the anal canal in human papillomavirus-infected individuals. Gastroenterology (2001) 1.22

Clinical impact of capsule endoscopy compared to push enteroscopy: 1-year follow-up study. Endoscopy (2005) 1.22

Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology (1999) 1.22

Are sphincter defects the cause of anal incontinence after vaginal delivery? Results of a prospective study. Dis Colon Rectum (2000) 1.22

Regression of inflammatory pseudotumor of the liver under conservative therapy. Dig Dis Sci (1995) 1.21

Polymerase chain reaction assay for the detection of Helicobacter pylori in gastric biopsy specimens: comparison with culture, rapid urease test, and histopathological tests. Gut (1994) 1.19

Colonic metabolism of wheat starch in healthy humans. Effects on fecal outputs and clinical symptoms. Gastroenterology (1986) 1.18

Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. J Nucl Med (1997) 1.15

Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice or intestinal tumorigenesis in Apc(Min/+) mice. Gut (2005) 1.13

Cimetidine treatment of acute and chronic Zollinger-Ellison syndrome. World J Surg (1979) 1.11

Allelic diversity of the two transferrin binding protein B gene isotypes among a collection of Neisseria meningitidis strains representative of serogroup B disease: implication for the composition of a recombinant TbpB-based vaccine. Infect Immun (2000) 1.11

Intraductal papillary and mucinous pancreatic tumour: a new extracolonic tumour in familial adenomatous polyposis. Gut (2002) 1.10

Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients. Gut (1992) 1.10

Idiopathic pancreatitis associated with inflammatory bowel disease. Dig Dis Sci (1985) 1.10

Localization of gastrinomas by endoscopic ultrasonography in patients with Zollinger-Ellison syndrome. Surgery (1995) 1.10

Endocrine pancreatic tumours and helical CT: contrast enhancement is correlated with microvascular density, histoprognostic factors and survival. Pancreatology (2005) 1.10

Current approach to the management of tumoral process in patients with gastrinoma. World J Surg (1986) 1.09

Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine. Gut (2007) 1.09

Cystic dystrophy of the duodenal wall in the heterotopic pancreas: radiopathological correlations. J Comput Assist Tomogr (2000) 1.09

Predictive factors in the outcome of pseudocysts complicating alcoholic chronic pancreatitis. Gut (1997) 1.09

The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors. Am J Gastroenterol (2000) 1.09

Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease overproduction. Evidence for PI3 kinase and PKC involvement. Carcinogenesis (2001) 1.09

Multivariate analysis of pathophysiological factors in reflux oesophagitis. Gut (1997) 1.08

Diagnosis and treatment of Zollinger-Ellison syndrome. Baillieres Clin Gastroenterol (1988) 1.07

One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin. Aliment Pharmacol Ther (1998) 1.06

Oral Crohn disease: clinical characteristics and long-term follow-up of 9 cases. Arch Dermatol (1999) 1.06

Radioautographic and quantitative studies on parietal and peptic cell kinetics in the mouse. A selective effect of gastrin on parietal cell proliferation. Gastroenterology (1975) 1.06

Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with KRAS mutation assay to distinguish pancreatic cancer from pseudotumoral chronic pancreatitis. Endoscopy (2009) 1.06

Heterogeneity of tbpB, the transferrin-binding protein B gene, among serogroup B Neisseria meningitidis strains of the ET-5 complex. Clin Diagn Lab Immunol (1997) 1.06

Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas. Histopathology (2005) 1.05

Comparative genomic hybridization analysis of sporadic neuroendocrine tumors of the digestive system. Genes Chromosomes Cancer (1998) 1.05

Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gut (1995) 1.05

Mutational screening of the cationic trypsinogen gene in a large cohort of subjects with idiopathic chronic pancreatitis. Clin Genet (2001) 1.05